Skip to content
DataLookout
Menu

NCT07370584

A Safety Study of IVMED-85 Ophthalmic Solution in Healthy Adults

StatusCompleted
PhasePhase 1
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 29 words Show 4 more changesShow less
    • Trial completed
    • Primary completion date changed from estimate of May 2026 to Apr 1, 2026
    • Study completion date changed from estimate of Jul 2026 to May 13, 2026
    • Site details revised
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 2026 to Feb 4, 2026
    v3
  3. Minor Study title shortened, about 5 wordsv2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Visual acuity
Timeframe: From enrollment to the end of treatment at 6 weeks
Change in eye assessments
Timeframe: From enrollment to the end of treatment at 6 weeks
Punctal stenosis or Bloody discharge
Timeframe: From enrollment to the end of treatment at 6 weeks
Change in ocular assessments
Timeframe: From enrollment to the end of treatment at 6 weeks

Arms and interventions

Vehicle ophthalmic solutionPlacebo comparator

Vehicle ophthalmic solution, administered twice a day

IVMED-85 ophthalmic solutionExperimental

IVMED-85 ophthalmic solution (0.20 mg/mL)

Drugs: IVMED-85 ophthalmic solution, Vehicle Ophthalmic Solution

Sites

1 site in 1 country

  • Total Eye Care, P.A.Memphis, Tennessee, United States